NYSE ARCA | ETF
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index.
The index seeks to track the performance of the common stock ofU. S. exchange-listed biotechnology companies with at least one drug therapy approved by theU. S.
Food and Drug Administration (FDA) for marketing.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| IBRX | Immunitybio Inc | Healthcare | Biotechnology | 5.06% |
| DAWN | Day One Biopharmaceuticals Inc | Healthcare | Biotechnology | 3.87% |
| CRNX | Crinetics Pharmaceuticals Inc | Healthcare | Biotechnology | 3.22% |
| DCPH | Deciphera Pharmaceuticals LLC | Healthcare | Drug Manufacturers - Specialty & Generic | 3.02% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 2.81% |
| AUPH | Aurinia Pharmaceuticals Inc | Healthcare | Biotechnology | 2.71% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 2.67% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 2.62% |
| KALV | Kalvista Pharmaceuticals Inc | Healthcare | Biotechnology | 2.59% |
| APLS | Apellis Pharmaceuticals Inc | Healthcare | Biotechnology | 2.49% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 2.34% |
| NVAX | Novavax Inc | Healthcare | Biotechnology | 2.26% |
| DVAX | Dynavax Technologies Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 2.25% |
| SWTX | SpringWorks Therapeutics Inc | Healthcare | Biotechnology | 2.04% |
| FOLD | Amicus Therapeutics Inc | Healthcare | Biotechnology | 2.03% |
| VSTM | Verastem Inc | Healthcare | Biotechnology | 2.01% |
| SAGE | Sage Therapeutic | Healthcare | Biotechnology | 1.97% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 1.88% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 1.81% |
| NUVB | Nuvation Bio Inc | Healthcare | Biotechnology | 1.80% |